Tag: Margaret Hodge

The below Parliamentary question was asked by Margaret Hodge on 2016-10-07.

To ask the Secretary of State for Business, Energy and Industrial Strategy, how many companies have listed another company rather than an individual as the persons with significant control in that company as part of their company register since 6 April 2016.

Margot James

The number of companies that have listed another company, rather than an individual, as a person with significant control (PSC) for the period 6 April to 10 October is 64,964. A company can list more than one PSC. Therefore, the figure of 64,964 includes companies that have listed both an individual and another company as their PSC.

The below Parliamentary question was asked by Margaret Hodge on 2016-01-04.

To ask the Secretary of State for Health, how many women were tested for the BRCA1/2 gene mutation in each of the last five years.

George Freeman

NHS England offers BRCA testing to individuals with a greater than 10% chance of carrying the mutation, using a model based on the individual’s personal and family history of cancers. Data is not collected centrally on reasons for women choosing to take a test for the BRCA1/2 gene mutation.

The UK Genetic Testing Network is working with NHS England, the devolved administrations and the Health and Social Care Information Centre to collect and publish United Kingdom-wide data on molecular genetic testing activity. Data collection is expected to have been completed by the summer of 2016 with a full update prepared for publication by the end of the year. However, it is not intended that this will include specific data for BRCA1 and BRCA2 mutation testing activity.

The below Parliamentary question was asked by Margaret Hodge on 2016-09-02.

To ask the Secretary of State for Justice, how many times her Department has used the services of (a) PwC, (b) Deloitte, (c) Ernst and Young, (d) KPMG and (e) other consulting firms in the last three financial years; and what (i) work was undertaken and (ii) the cost to the public purse was on each such occasion.

Dr Phillip Lee

It has not been possible to answer this question in the time allowed. I will write to the right honourable member in due course.

The below Parliamentary question was asked by Margaret Hodge on 2016-09-02.

To ask the Secretary of State for Communities and Local Government, if he will publish a list of all secondees to his Department from (a) PwC, (b) Deloitte, (c) Ernst and Young, (d) KPMG and (e) other consulting firms in the last three financial years; and what the role was of each of those secondees.

Mr Marcus Jones

My department has not had any secondees in the last three financial years from any of the named companies requested.

However, my department has had a total of seven secondees from other consulting firms. Five of the seven roles were to help advise on specific housing and property issues, including three roles on the Private Rented Sector Taskforce. One other secondee is working in my Implementation Unit implementing reviews on housing and planning, and one secondee was working as a Crown Premises Fire Inspector. Only three of the seven secondees are still working in DCLG.

The below Parliamentary question was asked by Margaret Hodge on 2016-10-07.

To ask the Secretary of State for Business, Energy and Industrial Strategy, how many companies have disclosed information to Companies House on persons with significant control in their company as part of their company register since 6 April 2016.

Margot James

As at 10 October 2016, the total number of companies that have disclosed information on people with significant control (PSC) for the period 6 April to 10 October is 779,043.

The below Parliamentary question was asked by Margaret Hodge on 2016-01-04.

To ask the Secretary of State for Health, what information his Department holds on the reasons for women choosing to take a test for the BRCA1/2 gene mutation.

George Freeman

NHS England offers BRCA testing to individuals with a greater than 10% chance of carrying the mutation, using a model based on the individual’s personal and family history of cancers. Data is not collected centrally on reasons for women choosing to take a test for the BRCA1/2 gene mutation.

The UK Genetic Testing Network is working with NHS England, the devolved administrations and the Health and Social Care Information Centre to collect and publish United Kingdom-wide data on molecular genetic testing activity. Data collection is expected to have been completed by the summer of 2016 with a full update prepared for publication by the end of the year. However, it is not intended that this will include specific data for BRCA1 and BRCA2 mutation testing activity.

The below Parliamentary question was asked by Margaret Hodge on 2016-09-02.

To ask the Secretary of State for Northern Ireland, how many times his Department has used the services of (a) PwC, (b) Deloitte, (c) Ernst and Young, (d) KPMG and (e) other consulting firms in the last three financial years; and what (i) work was undertaken and (ii) the cost to the public purse was on each such occasion.

Kris Hopkins

The Department has used the services of (a) PwC, once in the last three financial years. This was for the provision of VAT advice. The cost to the public purse was £1,350. My department has not used the services of any other consultant firms in the last three financial years.

The below Parliamentary question was asked by Margaret Hodge on 2016-09-02.

To ask the Secretary of State for Culture, Media and Sport, if she will publish a list of all secondees to her Department from (a) PwC, (b) Deloitte, (c) Ernst and Young, (d) KPMG and (e) other consulting firms in the last three financial years; and what the role was of each of those secondees.

Matt Hancock

DCMS records show that there were no secondments to the Department from (a) PwC, (b) Deloitte, (c) Ernst and Young, (d) KPMG and (e) other consulting firms in the last three financial years.

The below Parliamentary question was asked by Margaret Hodge on 2016-10-07.

To ask the Secretary of State for Business, Energy and Industrial Strategy, with reference to the register of persons with significant control, what proportion of returns from companies have listed another company rather than an individual as the persons with significant control.

Margot James

As at 10 October 2016, the number of accepted filings from companies that have listed another company, rather than an individual as the people with significant control (PSC) is 66,304, equating to 8.4% of the 785,616 total number of accepted filings from companies that have listed PSC details.

The below Parliamentary question was asked by Margaret Hodge on 2016-01-04.

To ask the Secretary of State for Health, when the UK Genetics Testing Network plans to conduct an evaluation of genetic testing for BRCA1/2 mutations.

George Freeman

NHS England offers BRCA testing to individuals with a greater than 10% chance of carrying the mutation, using a model based on the individual’s personal and family history of cancers. Data is not collected centrally on reasons for women choosing to take a test for the BRCA1/2 gene mutation.

The UK Genetic Testing Network is working with NHS England, the devolved administrations and the Health and Social Care Information Centre to collect and publish United Kingdom-wide data on molecular genetic testing activity. Data collection is expected to have been completed by the summer of 2016 with a full update prepared for publication by the end of the year. However, it is not intended that this will include specific data for BRCA1 and BRCA2 mutation testing activity.